Cited by 5Bariatric Surgery and OutcomesDiabetes Treatment and ManagementPharmacology and Obesity Treatment

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Risk of Harm from Use of Sodium-Glucose Co-Transporter-2 (SGLT-2) Inhibitors in Patients Pre or Post Bariatric Surgery

Open access

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11695-022-06044-6

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Metadata

Authors
Sharma, M., Nayar, R., Graham, Y., Parretti, H. M., Abbott, S., Tahrani, A., Miras, A. D., Madhok, B., Singhal, R., & Mahawar, K.
Affiliations
  • Sunderland Royal Hospital (GB)
  • South Tyneside and Sunderland NHS Foundation Trust (GB)
  • University of East Anglia (GB)
  • University Hospital Coventry (GB)
  • Novo Nordisk (Denmark) (DK)
  • Imperial College London (GB)
  • University Hospitals of Derby and Burton NHS Foundation Trust (GB)
  • Heartlands Hospital (GB)
Corresponding author
Sharma, Mitesh
Venue
Obesity Surgery
Published
2022-04-28
Volume
32
Issue
7
Pages
2469-2470
ISSN
  • 0960-8923 (ISSN-L)
  • 1708-0428
OpenAlex
W4225100117
Cited by
5
References
7
Citations by year
2026: 1 · 2025: 2 · 2023: 2
FWCI
0.93
Type
journal article
Language
en
Open access
Locations
  • Obesity Surgery (publishedVersion)
  • PubMed (publishedVersion)
  • UEA Digital Repository (University of East Anglia) (submittedVersion)
  • University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
Topics
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
Keywords
SGLT2 inhibitors
MeSH terms
Sodium-Glucose Transporter 2 Inhibitors, Diabetes Mellitus, Type 2, Glucose, Humans, Hypoglycemic Agents, Obesity, Morbid, Sodium, Bariatric Surgery, Sodium-Glucose Transporter 2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review